Velmanase alfa approved for treatment of non-central nervous system manifestations of alpha-mannosidosis: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Velmanase-Alfa-Approved
Learn More
Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
Polygenic-Risk-Score-Testing-Embryo-Selection
Learn More
Section E6.7-6.12 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in solid tumors (includes supplemental material) (update of Cooley et al.)
Section-E67-E612-Technical-Standards
Learn More
Section E6.1–6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes (update of Mikhail et al.)
Section-E61-E66-Technical-Standards
Learn More
Addendum: Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
Addendum-CYP2C9-VKORC1
Learn More
Elivaldogene autotemcel approved for treatment of cerebral adrenoleukodystrophy (CALD) in males: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Elivaldogene-autotemcel-approved-CALD
Learn More
Omaveloxolone approved for patients aged 16 years and older with Friedreich ataxia (FRDA): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Omaveloxolone-Approved-FRDA
Learn More
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)
version-3-2-Secondary-Findings
Learn More
Updated recommendations for CFTR carrier screening: A position statement of the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)
Updated-recommendations-CFTR-carrier-screening
Learn More
Olipudase alfa approved for pediatric and adult patients with acid sphingomyelinase deficiency (ASMD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Olipudase-Alfa-Approved-ASMD
Learn More